Australia markets open in 5 hours 18 minutes

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
10.020.00 (0.00%)
As of 2:13PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 511.05B
Enterprise value 335.7B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)0.68
Price/book (mrq)1.10
Enterprise value/revenue 32.19
Enterprise value/EBITDA 78.11

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-16.50%
S&P500 52-week change 335.56%
52-week high 313.65
52-week low 36.92
50-day moving average 39.92
200-day moving average 310.80

Share statistics

Avg vol (3-month) 3374
Avg vol (10-day) 3212
Shares outstanding 51.1B
Implied shares outstanding 6N/A
Float 1.1B
% held by insiders 10.64%
% held by institutions 13.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Nov 2017
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin -24.45%
Operating margin (ttm)17.61%

Management effectiveness

Return on assets (ttm)3.44%
Return on equity (ttm)-31.61%

Income statement

Revenue (ttm)16.28B
Revenue per share (ttm)14.85
Quarterly revenue growth (yoy)-8.60%
Gross profit (ttm)7.73B
Net income avi to common (ttm)-3.98B
Diluted EPS (ttm)-3.63
Quarterly earnings growth (yoy)11.60%

Balance sheet

Total cash (mrq)1.74B
Total cash per share (mrq)1.58
Total debt (mrq)25.43B
Total debt/equity (mrq)231.67
Current ratio (mrq)1.03
Book value per share (mrq)9.07

Cash flow statement

Operating cash flow (ttm)506M
Levered free cash flow (ttm)1.38B